Differences in the Cardiometabolic Control in Type 2 Diabetes according to Gender and the Presence of Cardiovascular Disease: Results from the eControl Study
Table 3
Degree of CVRFs control (% and 95% CI) in different macrovascular complications according to sex.
CHD
Stroke
PAD
CHD + stroke
CHD + PAD
Stroke + PAD
CHD + stroke + PAD
= 32,313
= 18,768
= 8,420
= 3,670
= 2,312
= 1,265
= 411
Men
Women
Men
Women
Men
Women
Men
Women
Men
Women
Men
Women
Men
Women
HbA1c ≤ 7%
54.2 (53.4–54.9)
52.8 (51.7–53.9)
58.1 (57–59.1)
57.2 (56.0–58.5)
50.5 (49.1–51.9)
48.3 (45.8–50.8)
53.8 (51.5–56.0)
52.0 (48.8–55.2)
49.4 (46.8–52.0)
44.5 (39.0–50.1)
51.9 (48.5–55.4)
43.5 (36.5–50.6)
51.3 (45.3–57.4)
46.8 (32.0–61.6)
BP ≤ 140/90 mmHg
67.3 (66.0–66.7)
62.6 (61.7–63.6)
64.2 (63.3–65.2)
63.0 (61.9–64.2)
61.0 (59.8–62.3)
55.8 (53.5–58.1)
65.8 (63.8–67.8)
64.5 (61.1–67.4)
65.0 (62.8–67.3)
59.0 (53.9–64.0)
63.2 (60.0–66.3)
56.0 (49.5–62.5)
65.0 (59.7–70.4)
55.7 (42.9–68.6)
Nonsmoker
43.8 (43.1–44.4)
90.5 (89.9–91.0)
45.2 (44.2–46.2)
90.8 (90.1–91.4)
30.7 (29.6–31.9)
85.7 (84.1–87.3)
45.1 (43.1–47.2)
91.8 (90.2–93.4)
34.3 (32.1–36.5)
89.3 (86.2–92.5)
33.1 (30.1–36.1)
87.6 (83.3–91.8)
37.5 (32.2–42.9)
88.5 (80.3–96.8)
BMI ≤ 30 kg/m2
39.7 (38.9–40.5)
52.4 (51.2–53.5)
34.3 (33.3–35.4)
47.8 (46.4–49.2)
33.0 (31.7–34.4)
47.7 (45.0–50.3)
34.0 (31.8–36.2)
50.8 (47.2–54.3)
35.9 (33.4–38.4)
47.3 (41.3–53.2)
31.9 (28.6–35.3)
44.0 (36.2–51.8)
31.1 (25.4–36.8)
53.5 (38.0–69.0)
LDL ≤ 130 mg/dL
89.1 (88.6–89.5)
82.8 (82.0–83.7)
84.9 (84.1–85.7)
78.9 (77.8–79.9)
82.2 (81.1–83.2)
73.7 (71.4–75.9)
90.9 (89.6–92.9)
84.4 (82.0–86.8)
89.8 (88.2–91.4)
81.5 (76.9–86.0)
86.1 (83.6–88.5)
79.0 (73.0–85.0)
88.0 (84.0–92.1)
81.0 (68.6–93.3)
LDL ≤ 100 mg/dL
63.1 (62.3–63.8)
53.2 (52.0–54.3)
56.4 (55.3–57.5)
46.8 (45.5–48.1)
51.8 (50.4–53.2)
42.2 (39.6–44.7)
65.1 (62.9–67.3)
54.7 (51.4–57.9)
62.4 (59.8–65.0)
58.4 (52.6–64.1)
58.4 (54.9–62.0)
48.6 (41.3–56.0)
59.8 (53.7–65.9)
54.8 (39.1–70.5)
BMI: body mass index; BP: blood pressure; CHD: coronary heart disease; PAD: peripheral artery disease.
